Pediatric Obstructive Sleep Apnea
0
Pipeline Programs
3
Companies
4
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
1 programDevelopment of a Wearable Point of Care Monitoring Device for Pediatric Obstructive Sleep ApneaN/A1 trial
Active Trials
Inspire Medical SystemsMN - Golden Valley
1 programHypoglossal Nerve StimulationN/A2 trials
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Inspire Medical SystemsHypoglossal Nerve Stimulation
Inspire Medical SystemsHypoglossal Nerve Stimulation
Human BioSciencesDevelopment of a Wearable Point of Care Monitoring Device for Pediatric Obstructive Sleep Apnea
Angeles TherapeuticsAdenotonsillectomy
Clinical Trials (4)
Total enrollment: 256 patients across 4 trials
Hypoglossal Nerve Stimulation in Obstructive Sleep Apnea With Complete Concentric Collapse
Start: Dec 2026Est. completion: Jun 203120 patients
N/ANot Yet Recruiting
Pediatric Down Syndrome Post-Approval Study
Start: Feb 2025Est. completion: May 203060 patients
N/ARecruiting
NCT05052216Human BioSciencesDevelopment of a Wearable Point of Care Monitoring Device for Pediatric Obstructive Sleep Apnea
Development of a Wearable Point of Care Monitoring Device for Pediatric Obstructive Sleep Apnea
Start: Aug 2022Est. completion: Jan 2028120 patients
N/ARecruiting
Brain Changes in Pediatric OSA
Start: May 2022Est. completion: Jul 202456 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 256 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.